SLAS2024 speaker update: How tech is reducing failure rates in clinical trials
Drug Discovery World
JANUARY 26, 2024
He will go on to discuss the company’s move to Phase I clinical trials with a drug targeting Fragile-X Syndrome, a leading cause of autism and intellectual disabilities. The post SLAS2024 speaker update: How tech is reducing failure rates in clinical trials appeared first on Drug Discovery World (DDW).
Let's personalize your content